Ładuje się......
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
BACKGROUND: Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal function in people with hepatorenal syndrome, bu...
Zapisane w:
| Wydane w: | Cochrane Database Syst Rev |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley & Sons, Ltd
2017
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483765/ https://ncbi.nlm.nih.gov/pubmed/28953318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011532.pub2 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|